abstract |
The present disclosure relates to a multispecific molecule comprising a binding domain specific for antigen CD22 and a binding domain specific for antigen CD79a and / or CD79b, a composition comprising the same, and a method for treating, for example, autoimmune disease treatment Lt; RTI ID = 0.0 > both. ≪ / RTI > |